Summary
Computer modelling techniques were used to examine the economic consequences of intravenous chemotherapy of serious infection. Acquisition cost of the drug was found to be a poor predictor of global cost, since inclusion of the preparation and administration costs and projected laboratory and drug complication costs narrow, or even reverse, apparent cost differentials between drugs. Thus, the costs per day for acquisition/total treatment (in US dollars) are: penicillin $5/$30, gentamicin $1/$46, amikacin $26/$63, clindamicin $38/$57, metronidazole $12/$20 and cefotaxime $47/$60.
‘Triple therapy’ involving gentamicin ($0.40/dose) resulted in higher hospital costs than the equivalent regimen involving cefotaxime ($16/dose). Even when the purchase price is high, humanitarian considerations advocate the use of safe, predictable, efficacious drugs. Fortunately, the present analysis suggests that such drugs frequently result in the lowest total treatment cost. Current cost containment efforts that are based on acquisition costs only are flawed and may result in both suboptimal care and higher actual costs.
Similar content being viewed by others
References
Gladen HE, Jackson JD, Jordan JT. Antibiotics, DRGs, and the personal computer: simple techniques to estimate true cost. Infections in Surgery 5: 559–567, 1986
Holloway JJ, Smith CR, Moore RD, et al. Comparative cost-effectiveness of gentamicin and tobramycin. Annals of Internal Medicine 101: 764–769, 1984
Kahlmeter G, Dahlager JL. Aminoglycoside toxicity — a review of clinical studies published between 1975 and 1982. Journal of Antimicrobial Chemotherapy 13 (Suppl. A): 9–22, 1984
Tanner DJ, Nazarian MQ. Cost containment associated with decreased parenteral antibiotic administration frequencies. American Journal of Medicine 148: 104–111, 1984
Veterans Administration Pharmacy Service Study Group. Non-drug variable cost per dose of preparing and administering small-volume cephalosporins. Journal of Hospital Pharmacy 41: 2624–2634,1984
Weinstein MC, Read JL, MacKay DN, Kresel JJ, Ashley H, et al. Cost-effective choice of antimicrobial therapy for serious infections. Journal of General Internal Medicine 1: 351–363, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gladen, H.E. Computer Modelling Antibiotic Therapy Costs. Drugs 35 (Suppl 2), 208–213 (1988). https://doi.org/10.2165/00003495-198800352-00046
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800352-00046